Definitive Healthcare EBIT per Share
The EBIT per Share of Definitive Healthcare (DH) as of Aug 9, 2026 is -1.92 USD. In the previous year, EBIT per Share was -6.18 USD — a change of -69.01% (higher).
Get this data via API
Financial Data API
EBIT per Share
-1.92USD
YoY
-69.01%
Last updated:
EBIT per Share of Definitive Healthcare is 2026 -1.92 USD. EBIT per Share of Definitive Healthcare was 2025 -6.18 USD. It decreases by -69.01% higher compared to the previous year.
Access this data via the Eulerpool API
Definitive Healthcare Stock analysis
What does Definitive Healthcare do? Definitive Healthcare Corp is a leading provider of software and information for companies in the healthcare industry. The company was founded in 2011 and is headquartered in Framingham, Massachusetts. Since its founding, the company has become one of the major providers of data and analysis in the healthcare industry.
The business model of Definitive Healthcare is based on providing comprehensive information and analysis for companies operating in the healthcare industry. This includes pharmaceutical and medical technology companies, as well as hospitals, clinics, and insurance companies. With the help of Definitive Healthcare's data and analysis, these companies can make better decisions and develop informed strategies.
Definitive Healthcare is divided into different segments to meet the varying needs of its customers. One of these segments is the provider segment, where information about healthcare facilities is collected and provided. Another segment is the pharmaceutical and biotech segment, where pharmaceutical companies can learn more about their customers and their needs. For the medical technology segment, information and analysis on the habits of their customers are provided.
Definitive Healthcare offers a variety of products that make it easier for its customers to achieve their business goals. One of the company's most important products is the Definitive Healthcare Platform Dashboard. The dashboard provides a comprehensive overview of the entire healthcare market and informs about the latest trends and developments. Another important product is the Definitive Medtech Suite, a platform that provides analysis and information for the medical technology segment.
Other products of Definitive Healthcare include the Definitive Pharmacy & Clinical Suite, which provides information and analysis for the pharmaceutical and biotech segment. The suite also includes a database of information on drugs and their usage. Another important product is the Definitive Hospital Insights Suite, which contains information about hospitals and healthcare facilities.
Definitive Healthcare has gained a good reputation in the industry and is now one of the major providers of data and analysis in the healthcare industry. The company is constantly striving to improve its products and services and provide its customers with a useful and relevant source of information. The focus of Definitive Healthcare is on providing data and analysis that help companies in the industry make informed decisions and achieve their business goals. Definitive Healthcare is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Definitive Healthcare stock
EBIT per Share of Definitive Healthcare is -1.92 USD in 2026.
EBIT per Share of Definitive Healthcare changed from -6.18 USD to -1.92 USD, representing a -69.01% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Definitive Healthcare since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Definitive Healthcare
All Key Metrics — Definitive Healthcare
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth